Antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2022–2023

  07 March 2025

The report reveals that resistance to certain antimicrobials in Campylobacter and some Salmonella strains remains high, particularly in humans and food-producing animals. However, combined resistance to critically important antimicrobials is low in Salmonella, Campylobacter, and E. coli. Significant progress has been made in reducing AMR in food-producing animals in several Member States (MSs), but the detection of carbapenemase-producing E. coli isolates in pigs, cattle, poultry, and meat requires further investigation. The report emphasizes the need for caution in the use of antimicrobials, monitoring carbapenem isolates closely, and addressing differences in antimicrobial use patterns and practices.

Further reading: EFSA
Author(s): EFSA
Healthy Animals  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!